Related Research Articles
An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated, or expressed at high levels.
A tumor suppressor gene, or anti-oncogene, is a gene that regulates a cell during cell division and replication. If the cell grows uncontrollably, it will result in cancer. When a tumor suppressor gene is mutated, it results in a loss or reduction in its function. In combination with other genetic mutations, this could allow the cell to grow abnormally. The loss of function for these genes may be even more significant in the development of human cancers, compared to the activation of oncogenes.
Susan Lee Lindquist, ForMemRS was an American professor of biology at MIT specializing in molecular biology, particularly the protein folding problem within a family of molecules known as heat-shock proteins, and prions. Lindquist was a member and former director of the Whitehead Institute and was awarded the National Medal of Science in 2010.
Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for "the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence". He has been selected to receive the 2015 Othmer Gold Medal.
Zbtb7, originally named Pokemon, is a gene that may act as a master switch for cancer, and is responsible for the proliferation of cancer throughout surrounding cells. The leader of the research team which discovered this, geneticist Pier Paolo Pandolfi from the Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City, said the gene is unique in that it is needed for other oncogenes to cause cancer. Discovery of the gene was first published in the January 2005 issue of Nature.
Nancy Hopkins, an American molecular biologist, is the Amgen, Inc. Professor of Biology at the Massachusetts Institute of Technology. She is a member of the National Academy of Sciences, the Institute of Medicine of the National Academy, and the American Academy of Arts and Sciences. She is known for her research identifying genes required for zebrafish development, and for her earlier research on gene expression in the bacterial virus, lambda, and on mouse RNA tumor viruses. She is also known for her work promoting equality of opportunity for women scientists in academia.
Cellular senescence is a phenomenon characterized by the cessation of cell division. In their experiments during the early 1960s, Leonard Hayflick and Paul Moorhead found that normal human fetal fibroblasts in culture reach a maximum of approximately 50 cell population doublings before becoming senescent. This process is known as "replicative senescence", or the Hayflick limit. Hayflick's discovery of mortal cells paved the path for the discovery and understanding of cellular aging molecular pathways. Cellular senescence can be initiated by a wide variety of stress inducing factors. These stress factors include both environmental and internal damaging events, abnormal cellular growth, oxidative stress, autophagy factors, among many other things.
The Koch Institute for Integrative Cancer Research at MIT is a cancer research center affiliated with the Massachusetts Institute of Technology (MIT) located in Cambridge, Massachusetts, United States. The Institute is one of eight National Cancer Institute-designated basic research centers in the United States.
Angelika Amon was an Austrian American molecular and cell biologist, and the Kathleen and Curtis Marble Professor in Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Amon's research centered on how chromosomes are regulated, duplicated, and partitioned in the cell cycle. Amon was elected to the American Academy of Arts and Sciences in 2017.
Michael Thomas Hemann is an American cancer geneticist and associate professor in the David H. Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology. The research in Hemann's laboratory focuses on identification and characterization of genes involved in tumor formation, cancer progression, and chemotherapeutic response.
Cancer cells are cells that divide continually, forming solid tumors or flooding the blood with abnormal cells. Cell division is a normal process used by the body for growth and repair. A parent cell divides to form two daughter cells, and these daughter cells are used to build new tissue or to replace cells that have died because of aging or damage. Healthy cells stop dividing when there is no longer a need for more daughter cells, but cancer cells continue to produce copies. They are also able to spread from one part of the body to another in a process known as metastasis.
Ed Harlow is an American molecular biologist.
Duncan Odom is a research group leader at the German Cancer Research Center (DKFZ) in Heidelberg, and the Cancer Research UK Cambridge Institute at the University of Cambridge. Previously he was as an associate faculty member at the Wellcome Trust Sanger Institute from 2011 to 2018.
Anne Jacqueline Ridley is professor of Cell Biology and Head of School for Cellular and Molecular Medicine at the University of Bristol. She was previously a professor at King's College London.
Hazel L. Sive is a South African-born biologist and educator. She is Dean of the College of Science, and Professor of Biology at Northeastern University. Sive is a research pioneer, award-winning educator and innovator in the higher education space. Prior to June 2020, she was a Member of Whitehead Institute for Biomedical Research, Professor of Biology at Massachusetts Institute of Technology and Associate Member of the Broad Institute of MIT and Harvard. Sive studies development of the vertebrate embryo, and has made unique contributions to understanding how the face forms and how the brain develops its structure. Her lab also seeks to understand the origins of neurological and neurodevelopmental disorders, such as epilepsy, autism, Pitt–Hopkins syndrome and 16p11.2 deletion syndrome.
Anjana Rao, Ph.D., is a cellular and molecular biologist of Indian ethnicity, working in the US. She uses immune cells as well as other types of cells to understand intracellular signaling and gene expression. Her research focuses on how signaling pathways control gene expression.
Li Zhang is a biologist currently working at University of Texas at Dallas. She is a professor of Biological Sciences and the Cecil H. and Ida Green Distinguished Chair in Systems Biology Science at University of Texas at Dallas. During her 20+ years of independent research, Li Zhang has made major contributions to understanding of heme signaling and function in gene regulation, neuronal differentiation and survival, and lung cancer bioenergetics.
Alex K. Shalek is a biomedical engineer, and a core faculty member of the Institute for Medical Engineering and Science (IMES), an Associate Professor of Chemistry, and an Extramural Member of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. Additionally, he is a Member of the Ragon Institute and an Institute Member of the Broad Institute, an Assistant in Immunology at Massachusetts General Hospital, and an Instructor in Health Sciences and Technology at Harvard Medical School. The multi-disciplinary research of the Shalek Lab aims to create and implement broadly-applicable methods to study and engineer cellular responses in tissues, to drive biological discovery and improve prognostics, diagnostics, and therapeutics for autoimmune, infectious, and cancerous diseases. Shalek and his lab are best known for their work in single-cell genomics and for studying a number of devastating, but difficult to study, human diseases with partners around the world.
Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the Dana-Farber Cancer Institute. Her research focuses on longitudinal studies of patients with chronic lymphocytic leukemia (CLL).
Elizabeth Patton, Ph.D FRSE is professor of chemical genetics and group leader of Medical Research Council Institute for Genetics and Molecular Medicine (IGMM) Human Genetics Unit in Edinburgh, Personal Chair of Melanoma Genetics and Drug Discovery for a disease which kills 20,000 Europeans a year, and accounts for 80% of all skin cancer deaths. Her research into the genetic models and drug interactions testing, sharing international findings, is mainly using zebrafish in conjunction with the Edinburgh Cancer Research Centre. She holds a number of academic leadership roles in UK, Europe and international scientific bodies.
References
- 1 2 3 "The Koch Institute: Jacqueline A. Lees". ki.mit.edu. Retrieved 2020-05-18.
- ↑ "Corporation awards tenure to 23 faculty members". MIT News. Retrieved 2020-05-18.
- ↑ "Sizer CD Chair is established". MIT News. Retrieved 2020-05-18.
- ↑ Zhang, GuangJun; Hoersch, Sebastian; Amsterdam, Adam; Whittaker, Charles A.; Lees, Jacqueline A.; Hopkins, Nancy (2010-09-28). "Highly aneuploid zebrafish malignant peripheral nerve sheath tumors have genetic alterations similar to human cancers". Proceedings of the National Academy of Sciences. 107 (39): 16940–16945. doi: 10.1073/pnas.1011548107 . ISSN 0027-8424. PMC 2947874 . PMID 20837522.
- ↑ Iaquinta, Phillip J; Lees, Jacqueline A (2007-12-01). "Life and death decisions by the E2F transcription factors". Current Opinion in Cell Biology. Cell differentiation / Cell division, growth and death. 19 (6): 649–657. doi:10.1016/j.ceb.2007.10.006. ISSN 0955-0674. PMC 2268988 . PMID 18032011.